System chairman
Ochsner Health
Dr.Maged Guirguis serves as the system chair of the interventional pain management department at Ochsner Health. He is an associate professor for the University of Queensland-Ochsner Clinical School of Medicine and a clinical assistant professor for Louisiana State University School of Medicine in New Orleans. He's triple-board-certified in anesthesiology, pain medicine and headache management and has published numerous research papers and presented various studies and peer reviewed abstracts on pain medicine at both national and international meetings.
What Forms of AI Should Faculty and Fellows Be Learning?
Thursday, November 21, 2024
4:25 PM - 4:45 PM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)
EXP-04 - ePosters in Exhibit Hall
Thursday, November 21, 2024
5:15 PM - 5:45 PM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)
How to Run a Successful Academic Pain Practice
Friday, November 22, 2024
9:00 AM - 9:15 AM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)
Friday, November 22, 2024
1:30 PM - 3:30 PM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)
Practice Challenges and Opportunities in Neuromodulation
Saturday, November 23, 2024
8:00 AM - 10:00 AM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)
B&C Pearls: Peripheral Nerve Stimulation
Saturday, November 23, 2024
9:30 AM - 9:35 AM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)
WS-22 - Neuromodulation: Surgical Skills Including IDDS and SCS, Tunneling, Pocketing
Saturday, November 23, 2024
10:45 AM - 12:45 PM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)
WS-23 - Minimally Invasive Decompression
Saturday, November 23, 2024
2:15 PM - 4:15 PM PT
Disclosure(s): Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)